SAM
ADMA icon

Sawgrass Asset Management’s ADMA Biologics ADMA Stock Holding History

Sawgrass Asset Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,223
Closed -$186K – 181
2025
Q2 		$186K Sell
10,223
-1,716
-14% -$35K 0.02% 175
2025
Q1 		$237K Sell
11,939
-2,540
-18% -$43.9K 0.03% 159
2024
Q4 		$248K Sell
14,479
-2,005
-12% -$37.7K 0.03% 155
2024
Q3 		$330K Sell
16,484
-407
-2% -$6.33K 0.03% 146
2024
Q2 		$189K Sell
16,891
-1,377
-8% -$11.6K 0.02% 177
2024
Q1 		$121K Buy
18,268
+3,089
+20% +$16.9K 0.01% 186
2023
Q4 		$68.6K Sell
15,179
-226
-1% -$836 0.01% 200
2023
Q3 		$55.1K Buy
+15,405
New +$59.3K 0.01% 194

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Sawgrass Asset Management's ADMA Position: Q3 2025 in Review

Sawgrass Asset Management sold out of ADMA Biologics (ADMA) in Q3 2025, closing a stake of 10,223 shares — an estimated $186K sold.

Sawgrass Asset Management first reported a position in ADMA in Q3 2023 and held it in 8 quarters. The position peaked at $330K in Q3 2024. 365 funds tracked by Wall St. Rank hold ADMA as of Q3 2025.

  • Sawgrass Asset Management reported no remaining ADMA Biologics position as of Q3 2025 after selling out during the quarter.
  • Sawgrass Asset Management sold 10,223 ADMA Biologics shares in Q3 2025, an estimated $186K.
  • Sawgrass Asset Management first reported a position in ADMA Biologics in Q3 2023 and held it in 8 quarters.
  • Sawgrass Asset Management's ADMA Biologics position peaked at $330K in Q3 2024.
  • 365 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2025.

Based on Sawgrass Asset Management's 13F filing for Q3 2025, filed 31 Oct 2025.